DeepCyte ApS: Financial statements 2025
CVR: 45398293
Source: annual report 2025, Danish Business Authority
12/02/2025 – 31/12/2025
DeepCyte ApS (CVR 45398293) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 110,589 and a net result of DKK -2,283,309. The profit margin was -2,064.7%. Equity in the 2025 report amounted to DKK -2,243,309.
- Revenue
- DKK 110,589
- Gross Profit
- DKK -1,392,235
- Profit/Loss
- DKK -2,283,309
- Equity
- DKK -2,243,309
- Total Assets
- DKK 334,356
How creditworthy is DeepCyte ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of February 12, 2025, Carl Joseph Gabriel Evertsz has joined the board of directors of DeepCyte ApS.
As of February 12, 2025, Theodore Alexandrov has joined the board of directors of DeepCyte ApS.
As of February 12, 2025, Theodore Alexandrov is registered as director of DeepCyte ApS.
As of February 12, 2025, is registered as an owner of DeepCyte ApS with an ownership share of 100%.
DeepCyte ApS was founded on February 12, 2025.
About DeepCyte ApS
DeepCyte ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Theodore Alexandrov. The company is owned by DeepCyte Inc.. In 2025, the company reported revenue of DKK 110,589 and a net result of DKK -2,283,309. Equity in the 2025 report amounted to DKK -2,243,309.